Connor Tsuchida
FounderScientific Cofounder at Azalea Therapeutics
Berkeley, California, United States
FoundedAzalea Therapeutics
About
Connor Tsuchida is Scientific Co-Founder and Vice President of Research & Development at Azalea Therapeutics, a biotechnology company focused on molecular therapies. He completed a PhD in bioengineering at UC Berkeley and UC San Francisco in the laboratory of Jennifer Doudna, with prior training at the University of Washington, Pfizer, Harvard University, and the NYU School of Medicine. He was named to the Forbes 30 Under 30 Healthcare list in 2024.
Scientific Cofounder at Azalea Therapeutics
Intro paths
→
In turn, Connor can intro founders to Azalea Therapeutics's investors below.
Azalea Therapeutics's investors · 4
Co-founders at Azalea Therapeutics
JD

Jennifer DoudnaCo-founder, Nobel Laureate in Chemistry and Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, UC Berkeley
RB
Rodolphe BarrangouCo-founder, Associate Professor of Medicine, UCSF
KR
Krishnendu RoyCo-founder, Professor of Bioengineering, Stanford University
Experience
- Azalea TherapeuticsVice President, Research & Developmentcurrent2026 — present
- Azalea TherapeuticsScientific Co-Foundercurrent2023 — present
- University of California, San FranciscoSiebel Scholar2022 — 2023
- University of California, San FranciscoNIH Ruth L. Kirschstein Predoctoral NRSA F31 Fellow2021 — 2023
- University of California, San FranciscoPhD student | UC Berkeley - UC San Francisco Graduate Program in Bioengineering2017 — 2023
- University of California, BerkeleySiebel Scholar2022 — 2023
- University of California, BerkeleyNIH Ruth L. Kirschstein Predoctoral NRSA F31 Fellow2021 — 2023
- University of California, BerkeleyGraduate Student Researcher2018 — 2023
- University of California, BerkeleyPhD student | UC Berkeley - UC San Francisco Graduate Program in Bioengineering2017 — 2023
- University of California, BerkeleyGraduate Student Instructor2019 — 2022
- University of WashingtonUndergraduate Research Assistant2015 — 2017UW Medicine South Lake Union | Center for Cardiovascular Biology
- University of WashingtonMary Gates Research Scholar2016 — 2017
- University of WashingtonEmerging Leaders in Engineering: Priscilla and Melvin Wilson Endowed Scholar2016 — 2017
- University of WashingtonWashington Research Foundation Fellow2016 — 2017
- University of WashingtonInstructor2016
- Wyss Institute for Biologically Inspired EngineeringSummer Research Assistant2016Boston, MA
- NYU Langone Medical CenterSummer Undergraduate Research Program Scholar2016New York, NY
- Pfizer Global Product Research and DevelopmentSummer Research Intern2015Richmond, VA
Skills & more
Matlab16Microsoft Office13Microsoft Excel6Java1Microsoft Word3Cell Therapy1Gene Therapy1Genome EditingSingle Cell SequencingNext-Generation Sequencing (NGS)Western BlottingResearch16
+11 more
Project DesignTissue CultureStudent LeadershipProject ManagementMicrofluidicsChimeraFlow CytometryPublic SpeakingLeadershipTeamworkManagementLanguages English
From Connor's professional profile.
Frequently asked questions
- Who is Connor Tsuchida?
- Connor Tsuchida is Scientific Co-Founder and Vice President of Research & Development at Azalea Therapeutics, a biotechnology company focused on molecular therapies. He completed a PhD in bioengineering at UC Berkeley and UC San Francisco in the laboratory of Jennifer Doudna, with prior training at the University of Washington, Pfizer, Harvard University, and the NYU School of Medicine. He was named to the Forbes 30 Under 30 Healthcare list in 2024.
- Where does Connor Tsuchida work?
- Connor Tsuchida is Scientific Cofounder of Azalea Therapeutics.
- What companies did Connor Tsuchida found?
- Connor Tsuchida founded Azalea Therapeutics.
- Where did Connor Tsuchida go to school?
- Connor Tsuchida studied at University of California, Berkeley (Doctor of Philosophy - PhD, Bioengineering); University of California, San Francisco (Doctor of Philosophy - PhD, Bioengineering); University of Washington (Bachelor’s Degree, Bioengineering).
Same school
Also attended University of California, Berkeley1,453
Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport
+ 1,447 more
Also attended University of California, San Francisco67
Douglas CrawfordManaging General Partner at Mission BiocapitalLuke EvninAdvisor at MPM BioImpactCharles White, Ph.D.Principal at Illumina VenturesMatt MaurerInvestor at WVV CapitalAlec NielsenFounder & CEO, Asimov & Venture Partner at Pillar VCYvanka de SoysaAssociate at Foreground Capital
+ 61 more
Also attended University of Washington277
Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesJoe HorsmanInvestor at Madrona Venture Group
+ 271 more
Also attended Mead Senior High School1
Shared employers
Also worked at Azalea Therapeutics1
Also worked at University of California, San Francisco84
Logan HilleLife Sciences Analyst at CincyTechPaul JennyBoard Chair at CincyTechDavid KaufmanInvestor at Third Rock VenturesFrancisco GimenezInvestment Team at 8VCHani GoodarziFounder, Tahoe Therapeutics at Amplify PartnersCharles White, Ph.D.Principal at Illumina Ventures
+ 78 more
Also worked at University of California, Berkeley310
Ali GhodsiCo-founder & CEO of DatabricksRaquel UrtasunFounder & CEO of WaabiPaul JennyBoard Chair at CincyTechAndrea van ElsasInvestor at Third Rock VenturesMichael PerezDeputy General Counsel at Mucker CapitalFreada Kapor KleinFounding Partner at Kapor Capital
+ 304 more
Also worked at University of Washington95
Joe HorsmanInvestor at Madrona Venture GroupMike FridgenVenture Partner at Madrona Venture GroupSid ShenaiVenture partner at Madrona and co-founder and CEO of Proof DiagnosticsPaul JennyBoard Chair at CincyTechJason PrestonInvestor at Alsop Louie PartnersElliot HershbergScientist, Writer, and Investor on a mission to accelerate The Century of Biology
+ 89 more

































